Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OMER

Omeros

$14.54

0.44 (3.12%)

07:11
03/30/17
03/30
07:11
03/30/17
07:11
Hot Stocks
Omeros reports Phase 2 data on renal diseases candidate »

Omeros announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Apr

  • 06

    Jun

OMER

Omeros

$12.67

1.11 (9.60%)

07:06
03/28/17
03/28
07:06
03/28/17
07:06
Hot Stocks
Omeros announces presentation of OMS721 data »

Omeros announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Apr

  • 06

    Jun

OMER

Omeros

$11.56

0.2 (1.76%)

07:07
03/27/17
03/27
07:07
03/27/17
07:07
Hot Stocks
Omeros to present results from dose ranging study of OMS721 clinical trial »

Omeros Corporation …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Over a month ago
OMER

Omeros

$11.60

0.15 (1.31%)

16:08
03/16/17
03/16
16:08
03/16/17
16:08
Earnings
Omeros reports Q4 EPS (45c), consensus (56c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

OMER

Omeros

$12.04

0.37 (3.17%)

15:20
03/06/17
03/06
15:20
03/06/17
15:20
Options
Omeros options imply 12.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

OMER

Omeros

$12.17

0.02 (0.16%)

07:12
03/01/17
03/01
07:12
03/01/17
07:12
Hot Stocks
Omeros reports additional results from OMS721 Phase 2 trial »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
OMER

Omeros

$11.11

0.55 (5.21%)

07:03
12/07/16
12/07
07:03
12/07/16
07:03
Hot Stocks
Omeros announces OMS721 phase 2 data in HSCT-TMA patients to be presented at ITC »

Omeros announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$10.56

-0.35 (-3.21%)

07:11
12/06/16
12/06
07:11
12/06/16
07:11
Hot Stocks
Omeros to provide continued supply of OMS721 for pediatric patient »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$10.91

-0.4 (-3.54%)

07:12
12/05/16
12/05
07:12
12/05/16
07:12
Hot Stocks
Omeros says orphan GPCR program delivers new cancer immunotherapy target »

Omeros announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$12.39

-0.32 (-2.52%)

07:37
11/30/16
11/30
07:37
11/30/16
07:37
Hot Stocks
Omeros says international group receives EUR1.3M grant for brain injury study »

Omeros announced that an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 02

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.